Review
doi: 10.1002/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6.
Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
Affiliations
- PMID: 11592357
- DOI: 10.1002/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6
Item in Clipboard
Review
Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
Arthritis Rheum.
2001 Sep.
No abstract available
Similar articles
-
Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significance.J Rheumatol. 2006 May;33(5):1027-8. Epub 2006 Mar 15. J Rheumatol. 2006. PMID: 16541474 No abstract available.
-
Tumor necrosis factor-alpha blockade and the risk of vasculitis.J Rheumatol. 2004 Oct;31(10):1885-7. J Rheumatol. 2004. PMID: 15468348 No abstract available.
-
Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer.Arthritis Rheum. 2004 Jun;50(6):1703-6. doi: 10.1002/art.20312. Arthritis Rheum. 2004. PMID: 15188344 Review. No abstract available.
-
Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments.Rheum Dis Clin North Am. 2004 May;30(2):257-70, v. doi: 10.1016/j.rdc.2004.01.003. Rheum Dis Clin North Am. 2004. PMID: 15172039 Review.
-
Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.Arthritis Rheum. 2004 Apr 15;51(2):301-2. doi: 10.1002/art.20242. Arthritis Rheum. 2004. PMID: 15077278 Clinical Trial. No abstract available.
Cited by
-
Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease - A Case Series.J Ophthalmic Inflamm Infect. 2024 Jul 30;14(1):35. doi: 10.1186/s12348-024-00403-3. J Ophthalmic Inflamm Infect. 2024. PMID: 39078559 Free PMC article.
-
Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.Clin Rheumatol. 2013 Jun;32(6):743-53. doi: 10.1007/s10067-013-2252-0. Epub 2013 Apr 16. Clin Rheumatol. 2013. PMID: 23588881 Review.
-
Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis.GMS Ophthalmol Cases. 2023 Dec 12;13:Doc24. doi: 10.3205/oc000232. eCollection 2023. GMS Ophthalmol Cases. 2023. PMID: 38111472 Free PMC article.
-
New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients.Clin Rheumatol. 2006 Nov;25(6):929-33. doi: 10.1007/s10067-005-0097-x. Clin Rheumatol. 2006. PMID: 16328088
-
Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.Front Neurol. 2022 Mar 15;13:868525. doi: 10.3389/fneur.2022.868525. eCollection 2022. Front Neurol. 2022. PMID: 35418930 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
